These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18091544)

  • 1. Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury.
    Mota RA; Hernández-Espinosa D; Galbis-Martinez L; Ordoñez A; Miñano A; Parrilla P; Vicente V; Corral J; Yélamos J
    Crit Care Med; 2008 Feb; 36(2):526-34. PubMed ID: 18091544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.
    Mota RA; Sánchez-Bueno F; Saenz L; Hernández-Espinosa D; Jimeno J; Tornel PL; Martínez-Torrano A; Ramírez P; Parrilla P; Yélamos J
    Lab Invest; 2005 Oct; 85(10):1250-62. PubMed ID: 16127429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(ADP-ribosyl)ation regulates heat shock factor-1 activity and the heat shock response in murine fibroblasts.
    Fossati S; Formentini L; Wang ZQ; Moroni F; Chiarugi A
    Biochem Cell Biol; 2006 Oct; 84(5):703-12. PubMed ID: 17167533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.
    Tao X; Chen X; Hou Z; Hao S; Liu B
    World Neurosurg; 2017 Nov; 107():888-899. PubMed ID: 28642177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
    Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
    Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.
    Cover C; Fickert P; Knight TR; Fuchsbichler A; Farhood A; Trauner M; Jaeschke H
    Toxicol Sci; 2005 Mar; 84(1):201-8. PubMed ID: 15601672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic treatment with poly(ADP-ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury.
    Mota R; Sánchez-Bueno F; Berenguer-Pina JJ; Hernández-Espinosa D; Parrilla P; Yélamos J
    Br J Pharmacol; 2007 Aug; 151(7):998-1005. PubMed ID: 17533414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PJ34, an inhibitor of PARP-1, suppresses cell growth and enhances the suppressive effects of cisplatin in liver cancer cells.
    Huang SH; Xiong M; Chen XP; Xiao ZY; Zhao YF; Huang ZY
    Oncol Rep; 2008 Sep; 20(3):567-72. PubMed ID: 18695907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
    Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
    Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(ADP-ribose) polymerase 1 inhibition protects cardiomyocytes from inflammation and apoptosis in diabetic cardiomyopathy.
    Qin WD; Liu GL; Wang J; Wang H; Zhang JN; Zhang F; Ma Y; Ji XY; Li C; Zhang MX
    Oncotarget; 2016 Jun; 7(24):35618-35631. PubMed ID: 27027354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
    Wang Z; Li Y; Lv S; Tian Y
    J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase.
    Mabley JG; Jagtap P; Perretti M; Getting SJ; Salzman AL; Virág L; Szabó E; Soriano FG; Liaudet L; Abdelkarim GE; Haskó G; Marton A; Southan GJ; Szabó C
    Inflamm Res; 2001 Nov; 50(11):561-9. PubMed ID: 11766996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of rt-PA induced blood-brain barrier component degradation by the poly(ADP-ribose)polymerase inhibitor PJ34 after ischemic stroke in mice.
    Teng F; Beray-Berthat V; Coqueran B; Lesbats C; Kuntz M; Palmier B; Garraud M; Bedfert C; Slane N; Bérézowski V; Szeremeta F; Hachani J; Scherman D; Plotkine M; Doan BT; Marchand-Leroux C; Margaill I
    Exp Neurol; 2013 Oct; 248():416-28. PubMed ID: 23876515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase 1 inhibition prevents interleukin-1β-induced inflammation in human osteoarthritic chondrocytes.
    Sun Y; Zhou L; Lv D; Liu H; He T; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2015 Jun; 47(6):422-30. PubMed ID: 25926140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
    Mukhopadhyay P; Rajesh M; Cao Z; Horváth B; Park O; Wang H; Erdelyi K; Holovac E; Wang Y; Liaudet L; Hamdaoui N; Lafdil F; Haskó G; Szabo C; Boulares AH; Gao B; Pacher P
    Hepatology; 2014 May; 59(5):1998-2009. PubMed ID: 24089324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.